Back to
HBK Investments L.P.
APGE
2 quarters
Position history for
HBK Investments L.P.'s holdings in APOGEE THERAPEUTICS INC
As of its Q2 2026 13F, HBK Investments held 2,850,000 shares of APGE (Apogee Therapeutics), worth $378.3M. APGE was 3.7% of HBK Investments' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$378.3M
Total Shares Change
-2.9M
Quarter-by-Quarter History